logo
Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs

Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs

Business Wire16-05-2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Liberate Bio, Inc., a biotechnology company developing medicines which efficiently and selectively deliver payloads to immune cells while bypassing the live, announced an oral presentation by Melissa Deck - Director of Platform, demonstrating the success of Liberate's RAPTOR™ screening platform and NHP data for the company's first lead candidates at the Oligonucleotide and Peptide Therapeutics 2025 (TIDES) being held May 19th-22nd, 2025 in San Diego, California.
'We built the RAPTOR platform to address key limitations of existing delivery vehicles and to expand the potential of oligonucleotide therapeutics beyond the liver. We are thrilled to have reached this critical inflection point,' said Walter R. Strapps, Ph.D., Chief Scientific Officer of Liberate. 'The presentation shows that our lead lipids robustly deliver mRNA cargo to monocytes and macrophages in non-human primates. This has enabled our first therapeutic program, in vivo CAR-M to treat solid tumors.'
Key Highlights from the Presentation:
Liberate Bio has built RAPTOR™, a robust nanoparticle screening platform for evaluating and identifying extrahepatic delivery vehicles directly in non-human primates (NHPs). RAPTOR™ has generated lipid nanoparticles (LNPs) with significant delivery to bone marrow and expression of mRNA cargo in monocytes, macrophages and other cell-types relevant to in vivo CAR therapy. At the same time, Liberate's lead candidates show a five -old reduction in liver accumulation of cargo.
TIDES Presentation Details:
TITLE: 'Innovating Nucleic Acid Delivery: RAPTOR, Artificial Intelligence, and the Future of CAR-M'
SESSION TITLE: Delivery of Macromolecules
PRESENTATION TYPE: Oral
PRESENTER: Melissa K. Deck, Director of Platform, Liberate Bio.
About Liberate Bio
Our vision at Liberate Bio is to achieve the extraordinary—delivering genetic medicines that transcend liver-based limitations, liberating patients from disease. Today's genetic medicines are limited by the availability of safe, effective delivery vehicles that direct nucleic acid therapeutics to any organ other than the liver. To realize the full potential of genetic medicines, we use our proprietary screening platform to rapidly evaluate rational and artificial intelligence-designed nanoparticles, reducing the cycle time for identifying novel vehicles from years to months. Our initial lead candidates are allowing us to pursue multiple therapeutic areas based on delivery to various bone marrow derived cells including HSCs, monocytes and macrophages. We have built the team and a suite of tools that allows us to rapidly move RNA therapeutics to the clinic by significantly increasing the translatability of the preclinical work.
For more information about the company's technologies, team, and mission, visit www.liberatebio.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Deel Launches AI Workforce
Deel Launches AI Workforce

Business Wire

time14 minutes ago

  • Business Wire

Deel Launches AI Workforce

SAN FRANCISCO--(BUSINESS WIRE)-- Deel, the leading global payroll and HR platform, today announced its AI Workforce, an integrated hub to launch, manage and create AI agents and workflows, hosted on the Deel platform. Deel AI Workforce will allow businesses to easily add AI agents to a company's workflow, surfacing information from Deel's HR and payroll platform, where critical data and core processes already live. Stretched payroll and HR teams are facing increasing demands and SHRM's latest Workforce Report shows that more than half of HR professionals say their teams are understaffed. Deel AI Workforce meets these challenges head-on, relieving HR leaders of admin-heavy tasks like approvals, suggesting actions in areas like recruitment and surfacing information to leaders to make smarter, real-time decisions. Deel AI Workforce will include 7 specialized AI agents designed for specific HR and payroll needs including: The Hiring Guru: A talent acquisition agent which instantly analyzes role requirements and budget to recommend the most strategic countries to source candidates, removing search burdens and improving hiring outcomes. The PTO Fairy: A time off agent which automatically analyzes requests, flags coverage gaps, and updates Deel so approvals happen faster without risking downtime. The Border Buddy: A compliance agent which geolocates IP addresses and compares them to local tax rules to keep 'work from anywhere' arrangements compliant. The Schedule Sheriff: A workforce planning agent which identifies scheduling gaps across time zones and shifts to ensure continuous coverage. The IT Guy: An IT equipment agent which recommends devices based on team roles and headcount to standardize procurement and boost efficiency. The Goodbye Genie: An offboarding agent which recommends the exact compliant offboarding steps based on location, worker type, and tenure to ensure a smooth and compliant process. The Payroll Detective: A payroll agent which flags payroll anomalies before payout, checking every variable against set rules and thresholds to prevent errors. Launching today in Beta, Deel customers can leverage the AI Workforce to instantly deploy pre-built functional agents across HR, payroll, talent acquisition, finance and operations. Each AI agent is built on the knowledge of 2,000+ in-country experts, able to instantly operate compliantly in 150+ countries and measurable, with the ability to track hours saved, tasks completed and errors reduced, inside the platform. Customers will also be able to build custom agents. Soon customers will be able to integrate other agents from tools like Slack and Zapier into Deel, making adoption natural and impact immediate. In the future AI agents will be a core part of the workforce, with employees able to manage, hire and fire agents based on business needs and workflow. 'AI agents mark a turning point for global work,' said Alex Bouaziz, Co-founder and CEO of Deel, 'For HR and payroll leaders that means going above simply automating tasks. It's about baking AI into already-used and loved technology to remove the barriers that slow teams down. This will allow human creativity, ideas, talent, and opportunities to move as freely as the businesses they power.' Deel customers can join the AI Workforce waiting list here. About Deel Deel is the all-in-one payroll and HR platform for global teams. Built for the way the world works today, Deel combines HRIS, payroll, compliance, benefits, performance, IT asset equipment management into one seamless platform. With AI-powered tools and a fully owned payroll infrastructure, Deel supports every worker type in 150+ countries—helping businesses scale smarter, faster, and more compliantly. Discover how Deel makes global work simple at

Seventh Holdings Completes Capital Raise to Invest in Residential Service Businesses
Seventh Holdings Completes Capital Raise to Invest in Residential Service Businesses

Business Wire

time14 minutes ago

  • Business Wire

Seventh Holdings Completes Capital Raise to Invest in Residential Service Businesses

LONG ISLAND CITY, N.Y.--(BUSINESS WIRE)-- Seventh Holdings LLC, a company focused on acquiring and operating residential service businesses, is proud to announce its formation following a successful capital raise. Founder Wyatt SaintClair, a driven operator, launched the firm to identify and invest in high-integrity local and regional businesses. Wyatt SaintClair brings a distinctive blend of strategic and operational experience to Seventh Holdings. SaintClair holds a materials engineering degree (magna cum laude, Tau Beta Pi) from Case Western Reserve University. He began his business career at McKinsey & Company, where he advised industrial companies on operations and M&A. He later joined a family-office private investment firm focused on long-term ownership and supported a top-100 national residential services company. Seventh Holdings is neither a private equity fund nor an industry strategic, allowing flexibility to owners seeking alternatives. Its holding company model allows for long-term, stable ownership. 'I started Seventh because I believe that with sound strategy and focused investment, great local businesses have tremendous potential. They deserve a successor who will honor their legacy, respect their history, and invest in their future,' says SaintClair. Seventh Holdings is particularly focused on acquiring recurring residential and commercial service businesses — such as irrigation system maintenance and automatic gate repair. Providing essential services, these businesses are operated by skilled teams with strong community ties. Seventh Holdings' board of directors includes founders and CEOs of businesses in the liquid waste, home health, multi-unit franchise, and security alarm monitoring industries. The firm focuses on continuity and growth— retaining valued employees, maintaining trusted customer relationships, and investing in steady growth. 'We're excited to partner with businesses that provide essential services, whose customers keep coming back, and employees see as family. These businesses deliver trusted consistent services, and our investment will fortify their future.' About Seventh Holdings LLC Seventh Holdings is a holding company focused on acquiring and operating residential service businesses. With committed capital, an experienced board of directors, and a driven founder, the firm partners with business owners seeking a long-term, values-driven successor who can move quickly with honesty and transparency.

Knowles to Participate in Upcoming Conferences
Knowles to Participate in Upcoming Conferences

Business Wire

time14 minutes ago

  • Business Wire

Knowles to Participate in Upcoming Conferences

ITASCA, Ill.--(BUSINESS WIRE)--Knowles Corporation (NYSE: KN), a leading manufacturer of specialty electronic components, including high performance capacitors, radio frequency ("RF") filters, advanced medtech microphones, and balanced armature speakers, today announced it will participate in upcoming conferences. Jeff Niew, President and CEO of Knowles will participate in The Jefferies Industrial Conference in New York City on September 3, 2025. Contact your Jefferies representative to schedule a meeting. Jeff Niew, President and CEO and John Anderson, CFO of Knowles will participate in the 16 th Annual Midwest Ideas Conference in Chicago on August 27, 2025. Contact Three Parts Advisors to schedule a meeting with management. About Knowles Knowles is a leading manufacturer of specialty electronic components. We design parts that perform unique, critical functions for innovative technologies. Through extreme reliability, custom engineering, and scalable manufacturing, we enable businesses to succeed in the most demanding applications across medtech, defense, and industrial markets. Our high-performance capacitors, RF and microwave filters, advanced medtech microphones, balanced armature speakers, and miniaturization products enable and enhance the performance of technologies with the power to change, improve, and save lives. Founded in 1946 and headquartered in Itasca, Illinois, Knowles has grown into a global organization with employees spanning 11 countries. For more information, please visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store